Q fever is a highly significant worldwide zoonosis caused by the bacterium Coxiella burnetii. While infection is commonly asymptomatic, 40% of primary infections in humans are symptomatic, with serious acute or chronic debilitating illnesses possible, including endocarditis, post-Q fever fatigue syndrome and recrudescent granulomatous lesions in bone or soft tissue 1, 2 . The bacterium itself has a duplicitous lifecycle; a metabolically active form obligately replicates within the macrophage cell lineage while an inactive form has extreme environmental resilience, providing a means to travel to new cells and new hosts. Coupled with a potentially large, seemingly asymptomatic reservoir encompassing wild and domestic mammals, birds and arthropods, this bacterium continues to raise important questions about its impact on public health worldwide. Given the targeted and complex nature of testing required to confirm a diagnosis in humans 3 , ongoing vigilance in promptly recognising clinical cases in humans and reappraisal of the potential risks created by animal exposure is required. This article outlines the current evidence on the potential role that cats and dogs might play in transmission of this bacterium and provides a framework for future studies.
Q fever has been traditionally framed as an occupational disease, associated with contact with cattle, sheep and goats in the livestock and meat industries. This has been both a help and a hindrance in identifying human cases and accurately assessing risk of exposure to C. burnetii. However, isolated reports of community-acquired Q fever have highlighted the potential role of pet dogs and cats as sources of this pathogen [4] [5] [6] [7] [8] [9] [10] [11] . Most reported cases have been asso- and dog ownership is not associated with increased seroprevalence of antibodies to C. burnetii 13 . However, the consequence of Q fever for those individuals at risk, such as unvaccinated veterinary personnel or breeders of pets, might be severe 8, 10 . Therefore, a broad and coordinated approach is required for future research from medical and veterinary clinicians and researchers in order to raise the profile of Q fever as a diagnostic consideration.
Determining C. burnetii infection in dogs and cats has been complicated by the lack of confirmed disease associations and the absence of standardised sensitive and specific diagnostic techniques. Serological tests, on which diagnosis primarily relies, cannot be translated directly from one species to another without standardisation 14 . The World Organisation for Animal Health (OIE) reference test for serological diagnosis of C. burnetii remains the complement fixation tests (CFT) 15 . Although CFT is highly specific, indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) are frequently used in human medicine due to their higher sensitivity, earlier detection of seroconversion and comparative ease to perform 1, 14 . The standardisation of serological tests for determining C. burnetii exposure in cats and dogs has been hampered to some extent by the absence of clearly identified clinical disease associations in these animal species (limiting the ability to define true positives and negatives) and the dangers of laboratory culture of this bacterium, which requires PC3
facilities. The tendency of many researchers looking at the broader question of the prevalence of infection in dog and cat populations therefore has been to extrapolate diagnostic testing methods and cut-off points used for human serum or to use positive and negative controls from non-canine or non-feline species, which raises questions over the reliability of results.
The reports of isolated outbreaks of community-acquired Q fever related to dog or cat contact has stimulated opportunistic seroprevalence studies searching for answers as to how widespread infection of cats and dogs might be. In maritime Canada, exposure to parturient cats and newborn kittens has been identified as a significant risk factor for Q fever 16 , with seroprevalence of C. burnetii infection in cats in these regions varying from 6.2 to 32% [17] [18] [19] . In other countries (such as South Africa, Japan and the USA), seroprevalence has ranged from 1.9 to 42% [20] [21] [22] [23] . However, the serolo- 
